Dr. Michael R. Harrison, MD

Dr. Harrison practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Harrison's NPI, 1760674535, was assigned on August 15, 2007. Dr. Harrison graduated from Tulane School of Medicine in 2004. Dr. Harrison's North Carolina license number on file is 2011-00521.

Dr. Harrison's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Harrison's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Harrison is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Harrison to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harrison practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Harrison's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Harrison is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Harrison's licenses on file in 3 states: North Carolina, Wisconsin and Louisiana.

Dmand AI lists anemia, breast cancer, multiple myeloma and prostate cancer among the conditions Dr. Harrison treats.

CMS data shows 566 Medicare services from Dr. Harrison across 3 procedure codes in 2024, for 159 Medicare patients. Medicare paid $37,923 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 159 Medicare patients who saw Dr. Harrison in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harrison's median patient age at 73, with 16% women.

In 2024, Dr. Harrison wrote 483 Medicare Part D claims for 103 patients. 58% of them were for generic drugs. CMS names the drug for 367 of them, across 16 drugs with 11 or more claims each, at $2,454,898 in total drug cost. In 2023, CMS named 540 claims across 19 drugs.

Dr. Harrison accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harrison as offering telehealth.

Dmand AI links 336 papers to Dr. Harrison, published from 2007 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Fetal Diseases, Fetus and Sheep. Dr. Harrison has published most often in J Pediatr Surg. Dr. Harrison's most frequent co-authors are Nick Scott Adzick, MD, Michael Thornton Longaker, MBA, MD and Roy A. Filly, MD.

Dmand AI links Dr. Harrison to 4 clinical trials. Conditions studied include Kidney Neoplasms, Carcinoma, Renal Cell and Prostatic Neoplasms. Duke University sponsors the most, 2. Open Payments lists research payments to Dr. Harrison that name 1 trial.

CMS Open Payments shows 367 general payments to Dr. Harrison from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Exelixis Inc. paid the most, $164,169. It also lists 4 research payments totaling $5,445 from 2019 to 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Harrison, most recently CMS Stage 1 EHR in 2013.

Dr. Harrison graduated from Tulane School of Medicine in 2004. Dr. Harrison is a member of ASCO.

Dr. Harrison is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.